Review
doi: 10.1056/NEJM199908123410707.
Drug treatment of lipid disorders
Affiliations
- PMID: 10441607
- DOI: 10.1056/NEJM199908123410707
Item in Clipboard
Review
Drug treatment of lipid disorders
N Engl J Med.
.
No abstract available
Comment in
-
Drug treatment of lipid disorders.N Engl J Med. 1999 Dec 23;341(26):2020; author reply 2021. doi: 10.1056/NEJM199912233412617. N Engl J Med. 1999. PMID: 10617401 No abstract available.
-
Drug treatment of lipid disorders.N Engl J Med. 1999 Dec 23;341(26):2020-1. N Engl J Med. 1999. PMID: 10617402 No abstract available.
Similar articles
-
Adverse effects of the treatment for hyperlipidemia.Cardiol Clin. 1986 Feb;4(1):95-103. Cardiol Clin. 1986. PMID: 3518936
-
LDL = 5: Virtues and dangers of multidrug therapy of low-density lipoprotein cholesterol.Prev Cardiol. 2010 Spring;13(2):69-71. doi: 10.1111/j.1751-7141.2009.00052.x. Prev Cardiol. 2010. PMID: 20377808
-
[Treatment of high blood cholesterol in patients with coronary heart disease].Nihon Rinsho. 1994 Jul;52 Suppl(Pt 1):1088-94. Nihon Rinsho. 1994. PMID: 12436661 Review. Japanese. No abstract available.
-
[Drug combination therapies for patients with hyperlipidemia and its significance].Nihon Rinsho. 2001 Mar;59 Suppl 3:566-71. Nihon Rinsho. 2001. PMID: 11347133 Review. Japanese. No abstract available.
-
Current drug treatments for lipid management.Manag Care. 2002 Sep;11(9 Suppl):4-9. Manag Care. 2002. PMID: 12369341 Review. No abstract available.
Cited by
-
Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?Vasc Health Risk Manag. 2006;2(4):441-6. doi: 10.2147/vhrm.2006.2.4.441. Vasc Health Risk Manag. 2006. PMID: 17323598 Free PMC article. Review.
-
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia.Vasc Health Risk Manag. 2009;5:901-8. doi: 10.2147/vhrm.s4502. Epub 2009 Nov 16. Vasc Health Risk Manag. 2009. PMID: 20016845 Free PMC article. Review.
-
Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk.Curr Atheroscler Rep. 2000 Jan;2(1):29-35. doi: 10.1007/s11883-000-0092-2. Curr Atheroscler Rep. 2000. PMID: 11122722 Review.
-
GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.J Clin Invest. 2005 Dec;115(12):3634-40. doi: 10.1172/JCI23626. J Clin Invest. 2005. PMID: 16322797 Free PMC article.
-
Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials.Drugs Aging. 2007;24(1):57-61. doi: 10.2165/00002512-200724010-00004. Drugs Aging. 2007. PMID: 17233547
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
